APA (7th ed.) Citation

R, W., N, T., S, Y., Y, K., & T, M. (2024). Minimal Involvement of P-gp and BCRP in Oral Absorption of Ensitrelvir, An Oral SARS-CoV-2 3C-like Protease Inhibitor, in a Non-Clinical Investigation. Journal of pharmaceutical sciences, 113(9), 2871. https://doi.org/10.1016/j.xphs.2024.06.009

Chicago Style (17th ed.) Citation

R, Watari, Tamura N, Yoshida S, Kido Y, and Matsuzaki T. "Minimal Involvement of P-gp and BCRP in Oral Absorption of Ensitrelvir, An Oral SARS-CoV-2 3C-like Protease Inhibitor, in a Non-Clinical Investigation." Journal of Pharmaceutical Sciences 113, no. 9 (2024): 2871. https://doi.org/10.1016/j.xphs.2024.06.009.

MLA (9th ed.) Citation

R, Watari, et al. "Minimal Involvement of P-gp and BCRP in Oral Absorption of Ensitrelvir, An Oral SARS-CoV-2 3C-like Protease Inhibitor, in a Non-Clinical Investigation." Journal of Pharmaceutical Sciences, vol. 113, no. 9, 2024, p. 2871, https://doi.org/10.1016/j.xphs.2024.06.009.